Copertina

Real‐life use of letermovir prophylaxis for cytomegalovirus in heart transplant recipients

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Grégoire Saltiel, Emmanuel Faure, Ady Assaf, Marie‐Charlotte Chopin, Fanny Moreau, Karine Faure, Céline Goeminne, Fanny Vuotto
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	Clinical Transplantation
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

The impact of active cytomegalovirus infection on donor‐derived cell‐free DNA testing in heart transplant recipients
di: Amit H. Alam, et al.
Pubblicazione: (2024)

Postoperative cognitive dysfunction in heart transplantation recipients
di: Qian Qin, et al.
Pubblicazione: (2024)

Prevalence of iron deficiency and anemia in pediatric heart transplant recipients
di: David M. Newland, et al.
Pubblicazione: (2024)

Which allogeneic hematopoietic cell transplant recipients have an increased risk for delayed‐onset clinically significant cytomegalovirus infection after letermovir prophylaxis?
di: Maria Alejandra Mendoza, et al.
Pubblicazione: (2024)

Cardiac allograft vasculopathy in heart transplant recipients from hepatitis C viremic donors
di: Bernard S. Kadosh, et al.
Pubblicazione: (2024)

Long‐term outcomes for pediatric heart transplant recipients transitioning to adult care teams
di: Elena M. Donald, et al.
Pubblicazione: (2024)

Evaluating the efficacy and safety of letermovir compared to valganciclovir for the prevention of human cytomegalovirus disease in adult lung transplant recipients
di: Sydni Martinez, et al.
Pubblicazione: (2024)

Immune outcomes of lung transplant recipients with different cytochrome P450 3A5 phenotypes after discontinuation of voriconazole antifungal prophylaxis
di: Zoe H. Tu, et al.
Pubblicazione: (2024)

Hepatitis C viremic lung transplantation to aviremic recipients: Comprehensive outcomes and post‐transplant viremia
di: Sarah Khan, et al.
Pubblicazione: (2024)

Utility of a fusion protein T‐cell co‐stimulation blocker Belatacept in heart transplant recipients: Real world experience from a high volume center
di: Daniel Oren, et al.
Pubblicazione: (2024)

Lung transplantation in HIV seropositive recipients: An analysis of the UNOS registry
di: Jack K. Donohue, et al.
Pubblicazione: (2024)

Tixagevimab/cilgavimab for the prevention of COVID‐19 in solid organ transplant recipients
di: Emily Eribes, et al.
Pubblicazione: (2024)

Letermovir for cytomegalovirus prophylaxis in lung transplant recipients: A promising shift toward reduced myelotoxicity
di: Muath Alsharif, et al.
Pubblicazione: (2024)

Association of BKV viremia and nephropathy with adverse alloimmune outcomes in kidney transplant recipients
di: Christie Rampersad, et al.
Pubblicazione: (2024)

Analysis of the waitlist performance and post‐transplant outcomes of lung transplant in elderly recipients in Korea: A nationwide cohort study
di: Jin Ho Jang, et al.
Pubblicazione: (2024)

Regulatory T cells in kidney transplant recipients with LIMS1 rs893403 risk genotype
di: Safak Mirioglu, et al.
Pubblicazione: (2024)

Outcomes of older Black renal transplant recipients receiving basiliximab induction and early steroid withdrawal
di: Sarah E Bova, et al.
Pubblicazione: (2024)

Risk factors and outcomes of bloodstream infection from a urinary source in kidney transplant recipients
di: Emily M. Eichenberger, et al.
Pubblicazione: (2024)

Epidemiology and outcomes associated with enterococcal blood stream infection among liver and kidney transplant recipients
di: Kevin D. He, et al.
Pubblicazione: (2024)

Managing the significant drug‐drug interaction between isavuconazole and tacrolimus in solid organ transplant recipients
di: Jessica Hedvat, et al.
Pubblicazione: (2024)

Association of physical activity with fractures in kidney transplant recipients: A Korean nationwide cohort study
di: Sungmi Kim, et al.
Pubblicazione: (2024)

Cardiovascular outcomes in solid organ transplant recipients undergoing cardiac surgery: A matched pair analysis
di: Kitae Kim, et al.
Pubblicazione: (2024)

Influence of cardiac diagnosis on outcomes of pediatric heart‐lung transplantation
di: Sandeep Sainathan, et al.
Pubblicazione: (2024)

Low‐dose tissue plasminogen activator is safe and effective in treating major intracardiac thrombosis in liver transplant recipients
di: Christine Nguyen‐Buckley, et al.
Pubblicazione: (2024)

Alemtuzumab versus anti‐thymocyte globulin in kidney transplant recipients receiving a rapid steroid withdrawal regimen
di: Rachel A. Rikard, et al.
Pubblicazione: (2024)

Can a “broken heart” successfully be transplanted? A brief report
di: Lorenzo Giovannico, et al.
Pubblicazione: (2024)

Does lung procurement and exposure to Perfadex impact heart transplantation outcomes
di: David Blitzer, et al.
Pubblicazione: (2024)

Clinical performance of the iPREDICTLIVING tool for the prediction of the post‐transplant recipient and living donor outcomes in a European cohort
di: Manuela Almeida, et al.
Pubblicazione: (2024)

Letter to the editor: Poor sensitivity of anti‐nucleocapsid antibody in detecting prior COVID‐19 in vaccinated solid organ transplant recipients
di: Jennifer L. Alejo, et al.
Pubblicazione: (2024)

Assessment of immunosuppression induction with basiliximab compared to antithymocyte‐globulin in adult heart transplant patients
di: Theresa E. Eberhardt, et al.
Pubblicazione: (2024)

COVID‐19 infection in patients with history of pediatric heart transplant in Germany, Austria, and Switzerland
di: Sarah Ulrich, et al.
Pubblicazione: (2024)

Psychological assessment of patients on the heart transplant waiting list: A single center experience
di: Simona De Santis, et al.
Pubblicazione: (2024)

Financial impact of donation after circulatory death heart transplantation: A single‐center analysis
di: Marian Urban, et al.
Pubblicazione: (2024)

Impact of age over 70 years in the new allocation system on the outcomes of heart transplantation in the US
di: Marco Gemelli, et al.
Pubblicazione: (2024)

A heart transplant center experience with basiliximab induction strategies: A double edged sword?
di: Luise Holzhauser, et al.
Pubblicazione: (2024)

Secondary anti‐viral prophylaxis in solid organ transplant recipients for the prevention of cytomegalovirus relapse: A systematic review and meta‐analysis
di: David Moynan, et al.
Pubblicazione: (2024)

Sociodemographic disparities in sodium‐glucose cotransporter‐2 inhibitor use among US kidney transplant recipients: An observational study of real‐world pharmacy records
di: Krista L. Lentine, et al.
Pubblicazione: (2024)

Effectiveness of combined plasma cell therapy and costimulation blockade based desensitization regimen in heart transplant candidates
di: Nadia Fida, et al.
Pubblicazione: (2024)

Donor heart dysfunction and graft survival in liver and kidney transplants—A register‐based study from Sweden
di: Carl Johan Svensson, et al.
Pubblicazione: (2024)

Mortality and morbidity after combined heart and liver transplantation in the failing Fontan: An updated dual center retrospective study
di: Sumeet S. Vaikunth, et al.
Pubblicazione: (2024)